期刊
HAMOSTASEOLOGIE
卷 32, 期 1, 页码 22-27出版社
GEORG THIEME VERLAG KG
DOI: 10.5482/ha-1178
关键词
Hyperfibrinolysis; trauma; ROTEM; TEG; tranexamic acid
类别
资金
- Ludwig Boltzmann Institute
- Baxter
- CSL Behring
- Fresenius Kabi
- GlaxoSmithKline
- Tern International
- NovoNordisk
- CSL Behring and Tern International
Trauma-induced coagulopathy (TIC) has been considered for a long time as being due to depletion of coagulation factors secondary to blood loss, dilution and consumption. Dysfunction of the remaining coagulation factors due to hypothermia and acidosis is assumed to additionally contribute to TIC. Recent data suggest that hyperfibrinolysis (HF) represents an additional important confounder to the disturbed coagulation process. Severe shock and major tissue trauma are the main drivers of this HF. The incidence of HF is still speculative. According to visco-elastic testing of trauma patients upon emergency room admission, HF is present in approximately 2.5-7% of all trauma patients. However, visco-elastic tests provide information on severe forms of HF only. Occult HF seems to be much more common but diagnosis is still challenging. Results from a recent randomized, placebo-controlled trial suggest that the early treatment of trauma patients with tranexamic acid may result in a significant reduction of trauma-associated mortality.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据